1. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. Issue 5 (10th January 2018) Authors: Sulis, M.L.; Blonquist, T.M.; Stevenson, K.E.; Hunt, S.K.; Kay‐Green, S.; Athale, U.H.; Clavell, L.A.; Cole, P.D.; Kelly, K.M.; Laverdiere, C.; Leclerc, J.M.; Michon, B.; Schorin, M.A.; Welch, J.G.; Neuberg, D.S.; Sallan, S.E.; Silverman, L.B. Journal: Pediatric blood & cancer Issue: Volume 65:Issue 5(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES. (12th June 2019) Authors: Kelly, K.M.; Daw, S.; Mauz‐Körholz, C.; Mascarin, M.; Michel, G.; Cooper, S.; Beishuizen, A.; Leger, K.J.; Garaventa, A.; Buffardi, S.; Brugières, L.; Harker‐Murray, P.; Cole, P.D.; Drachtman, R.A.; Manley, T.; Francis, S.; Sacchi, M.; Leblanc, T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗